| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 29, 2010Results of Study Published in NEJM and Presented at ADA Could Redefine the Standard of Care for People with Type 1 Diabetes
MINNEAPOLIS, Jun 29, 2010 (BUSINESS WIRE) -- In the longest and largest randomized, controlled study of sensor-augmented insulin pump therapy in type 1 diabetes, adult and pediatric patients using...
-
Jun 25, 2010Semi-Closed Loop System Designed to Reduce Severity and Duration of Hypoglycemia
MINNEAPOLIS, Jun 25, 2010 (BUSINESS WIRE) --Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. (NYSE:MDT) today announced that the first patient has been...
-
Jun 17, 2010New Data Released at Cardiostim 2010 Shows Benefits of Advanced Shock Reduction Technologies
MINNEAPOLIS & NICE, France, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) today announced European launch of the Protecta(TM)portfolio of implantable cardioverter-defibrillators (ICDs)...
-
Jun 7, 2010iPro(TM)2 Professional CGM Provides Simple Way to Reveal Insights Into Glucose Control Not Possible With Standard Glucose Assessment Methods
MINNEAPOLIS, Jun 07, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) announced today the launch of iPro(TM)2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to...
-
May 13, 2010New Medtronic Evidence on Shock Reduction Device Programming Strategies Released At Heart Rhythm 2010
MINNEAPOLIS & DENVER, May 13, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) today released new evidence demonstrating that key shock-reduction programming strategies significantly reduced...
-
May 10, 2010New Option to Connect Patients and Clinics Underscores Medtronic's Ongoing Efforts to Improve Clinic Efficiency and Simplify Patient Follow-up
MINNEAPOLIS, May 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) announced today that it now offers the new Medtronic M-Link(TM) cellular accessory, which provides cardiac device patients...
-
Apr 27, 2010First-To-Market Feature Allows Integration of Data from Multiple Vendors' 12-lead Management Systems
REDMOND, Wash., Apr 27, 2010 (BUSINESS WIRE) --Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), today announced the launch of Version 4.1 of its LIFENET System....
-
Apr 22, 2010
MINNEAPOLIS, Apr 22, 2010 (BUSINESS WIRE) --Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA) has...
-
Apr 9, 2010Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis
MINNEAPOLIS, Apr 09, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today that the company was named a 2010 Medical Device Excellence Award (MDEA) winner for excellence in medical device...
-
Apr 7, 2010Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis that Affects Nearly 30 Million US Adults1
MINNEAPOLIS, Apr 07, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today the launch of a new Frontal Handpiece for its Hydrodebrider(TM) System, manufactured by the company's Ear Nose and...
-
Mar 17, 2010Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...
-
Mar 17, 2010Advisa DR MRI(TM) SureScan(TM) Represents the Most Advanced Pacing System from Medtronic that Combines MRI Compatibility with Exclusive Pacing Technology
MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the commercial availability of the Advisa DR MRI(TM) SureScan(TM) pacemaker in selected European...
-
Mar 16, 2010Partnerships with American College of Cardiology and Association of Black Cardiologists and Latest Data from IMPROVE HF Clinical Study All Aim to Drive Equitable Treatment
MINNEAPOLIS & ATLANTA, Mar 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced Every Patient First, a health equity initiative that, in partnership with health care providers,...
-
Mar 15, 2010Late Breaking Clinical Trial at 59th Annual Scientific Session of the American College of Cardiology (ACC) also Showed Shortened Cardiovascular Hospital Stays
MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from the CONNECT trial showing the median time to clinical decision was significantly...
-
Mar 14, 2010Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients
MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
-
Feb 19, 2010
REDMOND, Wash., Feb 19, 2010 (BUSINESS WIRE) -- Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today it received notice from the U.S. Food and Drug...
-
Feb 5, 2010Study Presented at the Combined Sections Meetings of the Triological Society, the most prestigious society in Otolaryngology, received the John J. Conley Resident Research Award (Eastern Section)
MINNEAPOLIS, Feb 05, 2010 (BUSINESS WIRE) -- Results of a clinical study presented Thursday, Feb. 4 at the annual Triological Society meetings in Orlando, Fla., suggest a sterile barrier sheath...
-
Jan 28, 2010First Release of STOP-AF Data on Medtronic Arctic Front(R) Cryoballoon for Paroxysmal Atrial Fibrillation Patients
MINNEAPOLIS, Jan 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today pivotal data for the Medtronic Arctic Front(R) CryoAblation Catheter System will be presented as a late...
-
Nov 29, 2009
MINNEAPOLIS & SAN ANTONIO--(BUSINESS WIRE)--Nov. 17, 2009-- Medtronic, Inc. (NYSE:MDT) today announced the grand opening of its new Diabetes Therapy Management and Education Center in San Antonio....
-
Nov 24, 2009Non-GAAP diluted EPS of $0.77 grew 15%; GAAP diluted EPS of $0.78 grew 63%
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 24, 2009-- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009. The company...
-
Nov 13, 2009On World Diabetes Day, Medtronic Highlights the Growing Clinical Evidence for the Benefits of Continuous Glucose Monitoring in Diabetes Control
MINNEAPOLIS--(BUSINESS WIRE)--Nov. 13, 2009-- In acknowledgement of this year’s World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take...
-
Aug 22, 2006
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 22, 2006--Medtronic, Inc. (NYSE:MDT): -- Reported earnings of $599 million and diluted EPS of $0.51 grew 87% and 96%, respectively over the prior year's quarter....
-
Jun 2, 2006
MINNEAPOLIS--(BUSINESS WIRE)--June 2, 2006--Medtronic, Inc. (NYSE:MDT) will host an analyst and investor briefing Monday, June 12, 2006 in Washington D.C., during the American Diabetes Association...
-
May 23, 2006
MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...
-
Feb 21, 2006
MINNEAPOLIS--(BUSINESS WIRE)--Feb. 21, 2006--Medtronic, Inc. (NYSE:MDT): -- Company-wide Revenue Increased 9% (Constant Currency Growth of 12%) -- Implantable Cardioverter Defibrillator (ICD)...